GSK signs shingles vaccine deal with China's Zhifei for around $3 bln

GSK signs shingles vaccine deal with China's Zhifei for around $3 bln

Source: 
Reuters
snippet: 

China's largest vaccines company Zhifei (300122.SZ) will pay British drugmaker GSK (GSK.L) 2.5 billion pounds ($3.05 billion pound) for the exclusive rights to distribute GSK's shingles vaccine in the world's No.2 pharmaceuticals market.